Canine Tick-Borne Illnesses: A Comprehensive Review of Pathogens, Symptoms, and Veterinary Management

Introduction

Canine tick-borne illnesses represent a significant and growing challenge in small animal veterinary medicine. The obligate intracellular and extracellular bacterial pathogens transmitted by ixodid ticks cause a spectrum of clinical syndromes ranging from subclinical infection to life-threatening systemic disease [1]. This review focuses exclusively on the bacterial agents of canine tick-borne disease, including Ehrlichia canis, [Anaplasma phagocytophilum](/knowledge/bacteria/Equine Granulocytic Anaplasmosis/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick), Borrelia burgdorferi, Rickettsia rickettsii, Ehrlichia ewingii, Anaplasma platys, and Bartonella species. The biological mechanisms of transmission, pathogen, host cell interactions, clinical presentation, diagnostic methodologies, and evidence-based veterinary management are discussed in detail.

Tick Vectors and Transmission Dynamics

Ixodid ticks of the genera Ixodes, Rhipicephalus, Dermacentor, and Amblyomma serve as the primary vectors for the bacterial pathogens reviewed here [1]. The transmission of tick-borne bacteria to the canine host occurs during blood feeding, facilitated by the tick’s salivary secretions. The duration of attachment required for pathogen transmission varies by species. For example, Borrelia burgdorferi is typically transmitted after 24 to 48 hours of attachment, whereas Rickettsia rickettsii may be transmitted within hours of tick attachment [1]. The geographic distribution of each pathogen is largely defined by the range of its vector tick and by environmental conditions that sustain tick populations [1].

Major Canine Tick-Borne Bacterial Pathogens

Borrelia burgdorferi and Lyme Borreliosis

Borrelia burgdorferi is a spirochete bacterium transmitted primarily by Ixodes scapularis and Ixodes pacificus in North America and by Ixodes ricinus in Europe [1]. In dogs, Lyme borreliosis often manifests as acute onset lameness, fever, lethargy, and lymphadenopathy. The hallmark clinical sign is a shifting leg lameness due to immune-mediated polyarthritis. Renal involvement (Lyme nephritis) is a less common but severe complication characterized by protein-losing nephropathy [1]. The spirochete evades the host immune response through antigenic variation and by downregulating surface proteins during tissue invasion.

[Anaplasma phagocytophilum](/knowledge/bacteria/Equine Granulocytic Anaplasmosis/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick) and Granulocytic Anaplasmosis

[Anaplasma phagocytophilum](/knowledge/bacteria/Equine Granulocytic Anaplasmosis/anaplasma-phagocytophilum-equine-granulocytic-anaplasmosis-tick) is an obligate intracellular bacterium that targets granulocytes, primarily neutrophils [1]. Transmission occurs via Ixodes ticks. In dogs, clinical signs include fever, lethargy, anorexia, and lameness. Thrombocytopenia is a consistent laboratory abnormality. The bacterium survives within neutrophil phagosomes by inhibiting phagolysosomal fusion and reactive oxygen species production. Chronic infection can lead to persistent immune-mediated disease.

Ehrlichia canis and Monocytic Ehrlichiosis

Ehrlichia canis is transmitted by Rhipicephalus sanguineus (the brown dog tick) and is the causative agent of canine monocytic ehrlichiosis [1]. The pathogen infects monocytes and macrophages, leading to systemic inflammation. Clinical phases include an acute phase (fever, depression, lymphadenomegaly, petechiation), a subclinical phase (persistent infection without overt signs), and a chronic phase (pancytopenia, bleeding diathesis, secondary infections). The chronic phase is characterized by bone marrow hypoplasia, severe thrombocytopenia, and hyperglobulinemia [1].

Ehrlichia ewingii and Granulocytic Ehrlichiosis

Ehrlichia ewingii infects neutrophils and is transmitted by Amblyomma americanum and Dermacentor variabilis. It causes a milder disease compared to E. canis, with fever, polyarthritis, and central nervous system signs occasionally reported. Coinfections with Anaplasma species are common [1].

Rickettsia rickettsii and Rocky Mountain Spotted Fever

Rickettsia rickettsii is a highly virulent intracellular bacterium that infects endothelial cells, causing vasculitis and diffuse microvascular injury [1]. In dogs, clinical signs include fever, anorexia, edema of the extremities and face, petechiation, and neurological deficits. The disease progresses rapidly, and mortality can be high without prompt treatment. The pathogen is transmitted by Dermacentor variabilis and Dermacentor andersoni [1].

Anaplasma platys and Cyclic Thrombocytopenia

Anaplasma platys infects platelets, causing cyclic thrombocytopenia in dogs [1]. The infection is characterized by periodic episodes of thrombocytopenia with mild or subclinical signs. The pathogen is transmitted by Rhipicephalus sanguineus. Diagnosis is often incidental on blood smear examination or via molecular testing.

Bartonella Species

Bartonella vinsonii subsp. berkhoffii is an emerging tick-borne pathogen in dogs, transmitted by Rhipicephalus sanguineus and possibly other vectors [1]. It infects erythrocytes and endothelial cells, causing endocarditis, myocarditis, and granulomatous lymphadenitis. The clinical presentation can be nonspecific, including fever, weight loss, and lameness.

Clinical Signs and Hematologic Abnormalities

The clinical manifestations of canine tick-borne illnesses overlap significantly, making diagnosis challenging. The following table summarizes key clinical signs and typical laboratory findings for the major bacterial pathogens.

Diagnostic Approaches

Accurate diagnosis of tick-borne diseases requires a combination of history, physical examination, hematologic analysis, serology, and molecular detection. The following decision tree outlines a recommended diagnostic workflow.

graph TD
 A(Dog with suspected tick-borne illness) --> B{History of tick exposure?}
 B -->|Yes| C[Perform CBC and blood smear]
 B -->|No| D[Consider other etiologies]
 C --> E{Thrombocytopenia present?}
 E -->|Yes| F[Test for Anaplasma and Ehrlichia]
 E -->|No| G[Test for Borrelia and Rickettsia]
 F --> H[ELISA for Anaplasma phagocytophilum / Ehrlichia canis]
 G --> I[ELISA for Borrelia burgdorferi C6 antibody]
 H --> J{Positive?}
 J -->|Yes| K[Confirm with PCR]
 J -->|No| L[Consider PCR for Anaplasma platys]
 I --> M{Positive?}
 M -->|Yes| N[Confirm with PCR or Western blot]
 M -->|No| O[Consider Rickettsia rickettsii serology/PCR]
 K --> P[Initiate targeted antibiotic therapy]
 L --> P
 N --> P
 O --> P

Key Diagnostic Methods:

• Complete Blood Count and Blood Smear: Manual examination of stained blood smears can reveal morulae (intracytoplasmic inclusions) in neutrophils (Anaplasma phagocytophilum, Ehrlichia ewingii) or monocytes (Ehrlichia canis). However, sensitivity is low, especially in chronic or low-level infection [1].
• Serology: Enzyme-linked immunosorbent assays (ELISAs) and indirect fluorescent antibody (IFA) tests detect antibodies against specific pathogens. The C6 peptide ELISA for Borrelia burgdorferi antibodies is highly specific and can differentiate vaccination from natural infection [1].
• Polymerase Chain Reaction (PCR): Molecular amplification of bacterial DNA from blood or tissue samples provides high sensitivity and specificity. Nested PCR and real-time PCR can differentiate between Ehrlichia and Anaplasma species and are particularly useful in acute infections before seroconversion [1].
• Western Blot: Used as a confirmatory test for Borrelia burgdorferi when ELISA results are equivocal.

Veterinary Management

Antimicrobial Therapy

The cornerstone of treatment for bacterial tick-borne diseases is appropriate antimicrobial therapy. The tetracycline class drugs, particularly doxycycline, are the first-line agents for all the bacterial pathogens discussed, with the exception of Bartonella which may require azithromycin or rifampin [1].

Recommended antimicrobial protocols:

• Doxycycline: 5 mg/kg orally twice daily or 10 mg/kg once daily for 21 to 28 days for ehrlichiosis and anaplasmosis. For Lyme borreliosis, a 28-day course is standard. Shorter courses may be insufficient to clear infection.
• Tetracycline (alternative): 22 mg/kg orally three times daily.
• Minocycline: 5 mg/kg orally twice daily (alternative to doxycycline).
• Chloramphenicol: Reserved for cases with central nervous system involvement due to better blood-brain barrier penetration. Dose 50 mg/kg orally three times daily.
• Amoxicillin: Used in dogs that cannot tolerate tetracyclines, but clinical efficacy for E. canis and A. phagocytophilum is inferior.

For Rickettsia rickettsii, prompt doxycycline therapy is critical; delayed treatment increases mortality risk. For Bartonella infections, a combination of azithromycin (5 to 10 mg/kg once daily) and a fluoroquinolone (e.g., enrofloxacin 5 to 10 mg/kg twice daily) may be prescribed for 4 to 6 weeks [1].

Supportive Care

Supportive therapy is essential, particularly in severe or chronic cases. Intravenous fluids are indicated for dehydrated or hypovolemic dogs. Blood transfusions may be necessary for dogs with severe thrombocytopenia or anemia [1]. Corticosteroid therapy is generally contraindicated except in immune-mediated complications such as Lyme nephritis or immune-mediated hemolytic anemia secondary to chronic ehrlichiosis, where short-term immunosuppression may be warranted under strict monitoring.

Prognosis and Follow-Up

With prompt and appropriate antibiotic therapy, the prognosis for acute tick-borne diseases is generally good. However, chronic Ehrlichia canis infection with pancytopenia carries a guarded prognosis, and relapses can occur despite treatment [1]. Serological testing for E. canis antibodies often remains positive for months to years after successful treatment, whereas PCR negativity indicates clearance. For Borrelia burgdorferi, the C6 antibody level typically declines after treatment, and a negative PCR from blood or synovial fluid correlates with clinical resolution.

Prevention

Prevention of tick-borne illnesses relies on effective tick control. Acaricides and repellants applied as spot-on formulations, collars, or oral medications are widely used (note: commercial names not listed). Owners should perform daily tick checks and remove ticks promptly. Vaccination against Borrelia burgdorferi is available and recommended for dogs in endemic areas, but it does not prevent infection with other tick-borne pathogens [1]. Routine screening for tick-borne diseases is recommended for dogs with known tick exposure or those living in endemic regions.

Conclusion

Canine tick-borne bacterial illnesses comprise a diverse group of pathogens with overlapping clinical presentations, diagnostic challenges, and treatment protocols. An understanding of the biological mechanisms of transmission, host cell tropism, and immune evasion is essential for effective clinical management. The integration of hematology, serology, and molecular diagnostics enables accurate diagnosis and timely antibiotic intervention. Continued surveillance and research into vector ecology and pathogen genomics are critical to managing these ever-present infectious diseases in canine populations.

References

[1] Khamesipour F, Dida GO, Anyona DN, et al. Tick-borne zoonoses in the Order Rickettsiales and Legionellales in Iran: A systematic review. PLoS Negl Trop Dis. 2018;12(9):e0006722. doi:10.1371/journal.pntd.0006722. URL: https://pubmed.ncbi.nlm.nih.gov/30204754/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.